ASTELLAS-1941-CL-0005



Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone
ipragliflozin
1941-CL-0005
NCT01117584
Diabetes Mellitus, Type 2
Phase 2
 
August 2015